Skip to main content
PRFX logo
PRFX
(NASDAQ)
PRF Technologies Ltd.
$2.34-- (--)
Loading... - Market loading

PRF Technologies (PRFX) Company Profile

Complete business overview, executive team, trading details, and corporate information.

PRF Technologies Ltd.
PRFXNASDAQHealthcareDrug Manufacturers - Specialty & Generic

About PRF Technologies

PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026. The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Phone972 3 7177050
Address
65 Yigal Alon St. Tel Aviv-Yafo, 6744316 Israel

Corporate Identifiers

CIK0001801834
CUSIPM77798201
ISINIL0011651580
SIC2834

Leadership Team & Key Executives

Dr. Ehud Geller Ph.D.
Interim Chief Executive Officer and Executive Chairman
Eyal Broder
Interim Chief Financial Officer
Dr. Sigal Aviel eMBA, Ph.D.
Chief Operating Officer
Rita Keynan M.Sc.
Vice President of Pharmaceutical Operations
Dr. Stephen A. Cooper D.M.D Ph.D.
Executive Vice President of Development